Biological E aims to produce 100 mn doses/month of Corbevax from Feb 2022

SynopsisBiological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which will enable the city-based company to deliver 300 Million doses as promised to the Centre, the company said.TOI-OnlineCorbevax has completed two Phase III…Continue Reading

Will produce 5 billion vaccine doses for India & world by end-2022: PM Modi at G20 meet

NEW DELHI: India will produce over five billion doses of Covid vaccines for the country and the world by the end of 2022, Prime Minister Narendra Modi announced on Saturday at the G-20 Summit in Rome, where the grouping met to discuss, among other issues, developments related to the global pandemic. Addressing the Summit’s first…Continue Reading